Key result
Bariatric surgery linked to ~67% lower diabetes incidence vs usual care regardless of eligibility.
Why the study?
Current eligibility criteria for bariatric surgery exclude patients with BMI <35 kg/m2 and those with BMI 35-40 kg/m2 without comorbidities, and long-term outcomes in these noneligible patients are unclear.
Does bariatric surgery reduce the incidence of type 2 diabetes and improve cardiovascular risk factors in obese patients who do not meet current eligibility criteria compared to usual care?
Cohort (n=4,047)
Does bariatric surgery reduce the incidence of type 2 diabetes and improve cardiovascular risk factors in obese patients who do not meet current eligibility criteria compared to usual care?
Bariatric surgery significantly reduces the incidence of type 2 diabetes and improves cardiovascular risk factors even in obese patients who do not meet current strict BMI eligibility criteria.
May broaden eligibility for bariatric surgery in diabetes prevention; extends observational data but leaves open need for RCTs.
OBJECTIVE: Patients with a BMI <35 kg/m(2) and patients with a BMI between 35 and 40 kg/m(2) without comorbidities are noneligible by current eligibility criteria for bariatric surgery. We used Swedish obese subjects (SOS) to explore long-term outcomes in noneligible versus eligible patients. RESEARCH DESIGN AND METHODS: The SOS study involved 2,010 obese patients who underwent bariatric surgery (68% vertical-banded gastroplasty, 19% banding, and 13% gastric bypass) and 2,037 contemporaneously matched obese controls receiving usual care. At inclusion, the participant age was 37-60 years and BMI was ≥34 kg/m(2) in men and ≥38 kg/m(2) in women. The effect of surgery was assessed in patients that do (n = 3,814) and do not (n = 233) meet current eligibility criteria. The date of analysis was 1 January 2012. The follow-up time was up to 20 years, with a median of 10 years. RESULTS: Cardiovascular risk factors were significantly improved both in noneligible and eligible individuals after 10 years of follow-up. Surgery reduced the diabetes incidence in both the noneligible (adjusted hazard ratio 0.33 [95% CI 0.13-0.82], P = 0.017) and eligible (0.27 [0.22-0.33], P < 0.001) groups. We could not detect a difference in the effect of surgery between the groups (adjusted interaction P value = 0.713). CONCLUSIONS: Bariatric surgery drastically reduced the incidence of type 2 diabetes both in noneligible and eligible patients and improved cardiovascular risk factors in both groups. Our results show that strict BMI cutoffs are of limited use for bariatric surgery prioritization if the aim is to prevent diabetes and improve cardiovascular risk factors.
No takes yet. Share an insight, caveat, or question.
Sjöholm et al. (2013) conducted a cohort in Obesity (n=4,047). Bariatric surgery vs. Usual care was evaluated on Diabetes incidence (HR 0.33, 95% CI 0.13-0.82, p=0.017). Bariatric surgery reduced diabetes incidence in both noneligible (HR 0.33; 95% CI 0.13-0.82) and eligible (HR 0.27; 95% CI 0.22-0.33) patients compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: